Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: Patient-reported outcomes from a Phase II randomized controlled trial

Author: Shikiar Richard   Heffernan Michael   Langley Richard   Willian Mary   Okun Martin   Revicki Dennis  

Publisher: Informa Healthcare

ISSN: 1471-1753

Source: Journal of Dermatological Treatment, Vol.18, Iss.1, 2007-01, pp. : 25-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content